Clearmind Medicine partners with Polyrizon for intranasal MEAI formulation

Go back to Clearmind Medicine partners with Polyrizon for intranasal MEAI formulation
(NASDAQ: CMND) Delayed: 1.16 -0.54 (31.76%)
Previous Close $1.70    52 Week High
Open $1.50    52 Week Low
Day High $1.56    P/E N/A 
Day Low $1.16    EPS
Volume 15,512,723       

(NASDAQ: PLRZ) Delayed: 11.24 -1.32 (10.51%)
Previous Close $12.56    52 Week High
Open $12.40    52 Week Low
Day High $12.72    P/E N/A 
Day Low $11.00    EPS
Volume 141,282